Lora Todorova

923 total citations
28 papers, 562 citations indexed

About

Lora Todorova is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics. According to data from OpenAlex, Lora Todorova has authored 28 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Economics and Econometrics. Recurrent topics in Lora Todorova's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Estrogen and related hormone effects (5 papers) and Menopause: Health Impacts and Treatments (5 papers). Lora Todorova is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Estrogen and related hormone effects (5 papers) and Menopause: Health Impacts and Treatments (5 papers). Lora Todorova collaborates with scholars based in Switzerland, United States and United Kingdom. Lora Todorova's co-authors include Christian Eichinger, Nicholas J. Shaheen, Gary W. Falk, Vincent A. Mukkada, Binita M. Kamath, Nanda Kerkar, Alastair Baker, Roderick H.J. Houwen, Hannah-Lise Schofield and Denise King and has published in prestigious journals such as PLoS ONE, Clinical Gastroenterology and Hepatology and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

Lora Todorova

28 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lora Todorova Switzerland 11 361 134 106 82 73 28 562
Yoshiteru Sumiyoshi Japan 14 253 0.7× 72 0.5× 155 1.5× 25 0.3× 462 6.3× 52 773
György Széles Hungary 14 89 0.2× 46 0.3× 70 0.7× 73 0.9× 49 0.7× 31 686
Vikram M. Narayan United States 17 283 0.8× 86 0.6× 130 1.2× 13 0.2× 219 3.0× 101 761
Philipp Gild Germany 14 296 0.8× 68 0.5× 109 1.0× 29 0.4× 254 3.5× 50 601
Daniel J. Kagedan Canada 12 272 0.8× 56 0.4× 272 2.6× 56 0.7× 173 2.4× 29 579
Florina Constantinescu United States 12 45 0.1× 200 1.5× 52 0.5× 12 0.1× 45 0.6× 22 494
Francesco Barbagallo Italy 14 278 0.8× 9 0.1× 58 0.5× 75 0.9× 188 2.6× 55 502
Shiva Yazdanyar Denmark 13 265 0.7× 105 0.8× 104 1.0× 18 0.2× 31 0.4× 17 752
Aarthi Balasubramanyam United States 11 69 0.2× 65 0.5× 51 0.5× 38 0.5× 62 0.8× 15 445

Countries citing papers authored by Lora Todorova

Since Specialization
Citations

This map shows the geographic impact of Lora Todorova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora Todorova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora Todorova more than expected).

Fields of papers citing papers by Lora Todorova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora Todorova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora Todorova. The network helps show where Lora Todorova may publish in the future.

Co-authorship network of co-authors of Lora Todorova

This figure shows the co-authorship network connecting the top 25 collaborators of Lora Todorova. A scholar is included among the top collaborators of Lora Todorova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora Todorova. Lora Todorova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fernandes, Jérôme, et al.. (2023). Incidence, prevalence, and treatment of anemia of non-dialysis-dependent chronic kidney disease: A retrospective database study in France. PLoS ONE. 18(7). e0287859–e0287859. 1 indexed citations
3.
Nappi, Rossella E., et al.. (2022). Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey. Maturitas. 167. 66–74. 32 indexed citations
4.
Minutolo, Roberto, Giuseppe Grandaliano, Robert Snijder, et al.. (2022). Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy. Journal of Nephrology. 36(2). 347–357. 5 indexed citations
5.
Baker, Alastair, Nanda Kerkar, Lora Todorova, Binita M. Kamath, & Roderick H.J. Houwen. (2018). Systematic review of progressive familial intrahepatic cholestasis. Clinics and Research in Hepatology and Gastroenterology. 43(1). 20–36. 82 indexed citations
6.
7.
Kamath, Binita M., Linda Abetz‐Webb, Ciara Kennedy, et al.. (2017). Development of a Novel Tool to Assess the Impact of Itching in Pediatric Cholestasis. Patient. 11(1). 69–82. 24 indexed citations
8.
Mukkada, Vincent A., Gary W. Falk, Christian Eichinger, et al.. (2017). Health-Related Quality of Life and Costs Associated With Eosinophilic Esophagitis: A Systematic Review. Clinical Gastroenterology and Hepatology. 16(4). 495–503.e8. 102 indexed citations
9.
Parini, Rossella, Raphael Schiffmann, Iain Fotheringham, & Lora Todorova. (2015). A Systematic Review of The Humanistic Burden of Disease In Patients With Fabry Disease. Value in Health. 18(7). A762–A762. 2 indexed citations
10.
Todorova, Lora, et al.. (2015). Researching health-related quality of life at a community level: results from a population survey conducted in Burgas, Bulgaria. Health Promotion International. 31(3). 534–541. 12 indexed citations
11.
Heymann, Anthony, et al.. (2014). Efficacy of Liraglutide in a Real-Life Cohort. Diabetes Therapy. 5(1). 193–206. 17 indexed citations
12.
Karasik, Avraham, Anthony Heymann, Paul W. Sternberg, et al.. (2013). Real Life Effects of Liraglutide Supports Those Shown in RCTs. Value in Health. 16(7). A432–A432. 1 indexed citations
13.
Todorova, Lora, et al.. (2012). PDB21 Direct Medical Costs of Diabetes-Related Complications in India. Value in Health. 15(7). A662–A662. 4 indexed citations
14.
Todorova, Lora, et al.. (2012). PDB45 Direct Medical Costs of Diabetes-Related Complications in Saudi Arabia. Value in Health. 15(4). A178–A178. 5 indexed citations
15.
Todorova, Lora, Pradana Soewondo, Barnaby Hunt, & Ketut Suastika. (2012). PDB39 Evaluation of the Long-Term Clinical and Economic Impact of a 1% HbA1C Reduction in Patients With Type 2 Diabetes in Indonesia. Value in Health. 15(7). A500–A500. 1 indexed citations
16.
Todorova, Lora, et al.. (2012). PDB20 Estimating the Direct Medical Costs Associated with Diabetes-Related Complications in Indonesia. Value in Health. 15(7). A662–A662. 3 indexed citations
17.
Radford, Martha J., et al.. (2012). PDB46 Direct Medical Costs of Treating Diabetes Related Complications in Mexico. Value in Health. 15(4). A178–A179. 2 indexed citations
18.
Todorova, Lora, et al.. (2012). PDB19 Estimating the Costs of Diabetes Mellitus: An Analysis in Malaysia. Value in Health. 15(7). A662–A662. 1 indexed citations
19.
Todorova, Lora, et al.. (2012). PDB47 Direct Medical Management Costs of Diabetes-Related Complications in Algeria. Value in Health. 15(4). A179–A179. 4 indexed citations
20.
Ho, Joanne, et al.. (2009). Budget Impact Analysis of Ixabepilone Used According to FDA Approved Labeling in Treatment-Resistant Metastatic Breast Cancer. Journal of Managed Care Pharmacy. 15(6). 467–475. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiteru Sumiyoshi Breakdown of academic impact, for papers by György Széles Breakdown of academic impact, for papers by Vikram M. Narayan Breakdown of academic impact, for papers by Philipp Gild Breakdown of academic impact, for papers by Daniel J. Kagedan Breakdown of academic impact, for papers by Florina Constantinescu Breakdown of academic impact, for papers by Francesco Barbagallo Breakdown of academic impact, for papers by Shiva Yazdanyar Breakdown of academic impact, for papers by Aarthi Balasubramanyam
Rankless by CCL
2026